Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov 21;8(11):e024909.
doi: 10.1136/bmjopen-2018-024909.

Use of multiple antidiabetic medications in patients with diabetes and its association with hypoglycaemic events: a case-crossover study in Jordan

Abdallah Y Naser  1 , Ian Chi Kei Wong  1   2 , Cate Whittlesea  1 , Maedeh Y Beykloo  1 , Kenneth K C Man  1   2   3 , Wallis C Y Lau  1 , Dana Abdel-Halim Hyassat  4 , Li Wei  1
Affiliations

Use of multiple antidiabetic medications in patients with diabetes and its association with hypoglycaemic events: a case-crossover study in Jordan

Abdallah Y Naser et al. BMJ Open. .

Abstract

Objective: To assess whether the use of multiple antidiabetic medications is associated with an increased risk of hypoglycaemia in patients with type 2 diabetes mellitus.

Design: A case-crossover study.

Setting: Cases were enrolled from the National Center for Diabetes, Endocrinology and Genetics in Amman, Jordan.

Participants: Patients were those with diabetes mellitus and reported incident of a hypoglycaemic event in their medical records during the period January 2007 to July 2017. Patients with multiple antidiabetic medications were those with at least two antidiabetic medications.

Primary outcome: History of antidiabetic medication use was extracted from the pharmacy records. The use of multiple antidiabetic medications during the risk window (before hypoglycaemia) was compared with a control window(s) (earlier time) of the same length after a washout period. Conditional logistic regression was applied to evaluate the OR of hypoglycaemia between the treatment groups. A secondary analysis was performed in patients with a blood glucose measurement of ≤70 mg/dL.

Results: 182 patients (106 females, 58.2%) were included in the study with an average age of 59.9 years (SD=9.9). The patients' average body mass index was 31.7 kg/m2 (SD=6.2). Compared with monotherapy, the OR of hypoglycaemic events for patients with multiple antidiabetic medications was 5.00 (95% CI 1.10 to 22.82). The OR was 6.00 (95% CI 0.72 to 49.84) for the secondary analysis patient group (n=94). Ten-fold increased risk was found in patients (n=155) with insulin and sulfonylurea-based combination therapy (OR 10.00;95% CI 1.28 to 78.12).

Conclusion: This study shows that the use of multiple antidiabetic medications appears to increase the risk of hypoglycaemic events. Patients and healthcare professionals should be extra vigilant when patients are on multiple antidiabetic medications therapy, especially the combination of sulfonylurea and insulin.

Keywords: antidiabetic medications; case-crossover; hypoglycaemicevents; multiple medications.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Risk and control windows in the study design.
Figure 2
Figure 2
Flow chart of the patients included in the case-crossover study.
See this image and copyright information in PMC

References

    1. Hanssen KF. Blood glucose control and microvascular and macrovascular complications in diabetes. Diabetes 1997;46 Suppl 2:S101–S103. 10.2337/diab.46.2.S101 - DOI - PubMed
    1. Riedel AA, Heien H, Wogen J, et al. . Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy. Pharmacotherapy 2007;27:1102–10. 10.1592/phco.27.8.1102 - DOI - PubMed
    1. Turner R, Cull C, Frighi V, et al. . Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus. J of the American Med Association 1999;281:2005–12. - PubMed
    1. Lavernia F, Adkins SE, Shubrook JH. Use of oral combination therapy for type 2 diabetes in primary care: Meeting individualized patient goals. Postgrad Med 2015;127:808–17. 10.1080/00325481.2015.1085293 - DOI - PubMed
    1. Zaccardi F, Davies MJ, Dhalwani NN, et al. . Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study. Lancet Diabetes Endocrinol 2016;4:677–85. 10.1016/S2213-8587(16)30091-2 - DOI - PubMed

Publication types

Substances